Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Case Report: A 19-Years Old Patient with Haemophilia a with High Response Inhibitor Screening and Quantitation and the Bethesda Method

Marianela Trejos Herrera, MD, Alicia Lopez Campos, MD

Blood (2016) 128 (22): 4956.

https://doi.org/10.1182/blood.V128.22.4956.4956

Published: 2016

Journal Articles

Circulating Levels of Rivaroxaban Provide Different Results in Different Clot Based and Amidolytic Assays. a Study on Patients Treated with Two Different Dosages of Rivaroxaban

Debra Hoppensteadt, PhD, Daneyal Syed, BS, Mateja Jezovnik, Pavel Poredos, Sermin Tetik, Omer Iqbal, MD, Jeanine M. Walenga, PhD, Jawed Fareed, PhD

Blood (2014) 124 (21): 5084.

https://doi.org/10.1182/blood.V124.21.5084.5084

Published: 2014

Journal Articles

Detection of Lupus Anticoagulant In Women with Obstetric complications

Andrea Laura Avigliano, Bioq, Juan Carlos Galli, Bioq, Beatriz Grand, MD

Blood (2010) 116 (21): 3185.

https://doi.org/10.1182/blood.V116.21.3185.3185

Published: 2010

Journal Articles

Increased Anti-Protein Z and Protein S Antibodies in Patients with Anti-Phospholipid Antibodies and/or Lupus Inhibitor.

Yale S. Arkel, MD, De-Hui W. Ku, PhD, Evelyn Y. Ku, Jeffrey Birnbaum, Xuam Lam, BS

Blood (2006) 108 (11): 4030.

https://doi.org/10.1182/blood.V108.11.4030.4030

Published: 2006

Journal Articles

Changes in Components of the Natural Coagulation Inhibitor System, in Patients with Antiphospholipid Antibodies and/or the Lupus Inhibitor.

Yale S. Arkel, MD, De-Hui W. Ku, PhD, Evelyn Y. Ku, Jeffrey Birnbaum, Xuam Lam, BS

Blood (2006) 108 (11): 4031.

https://doi.org/10.1182/blood.V108.11.4031.4031

Published: 2006

Journal Articles

High Prevalence of Anti-Protein Z and Anti-Protein S Antibodies in Patients with Other Serological Markers for Antiphospholipid Antibodies.

De-Hui W. Ku, PhD, Yale S. Arkel, MD, Xuan Lam, BS, Paresh Patel, MD

Blood (2005) 106 (11): 2152.

https://doi.org/10.1182/blood.V106.11.2152.2152

Published: 2005

Journal Articles

Clinical Impact of Increasing the Sensitivity of Activated Partial Thromboplastin Time (aPTT) Reagent for Lupus Anticoagulant.

Mohammad Razaq, MD, Venkata Samavedi, MD, Allan Reiss, PhD, Nagender Mankan, MD, Anju Ohri, MD

Blood (2005) 106 (11): 4106.

https://doi.org/10.1182/blood.V106.11.4106.4106

Published: 2005

Journal Articles

Physiologic Inhibitors of Coagulation, Thrombophilic Acquired Factors and Venous Thromboembolism in Gastrointestinal Cancer Patients.

Gaia Schiavon, MD, Odoardo M. Olimpieri, MD, Barbara Giannetti, BSc, Maria C. Tirindelli, MD, Annalisa La Cesa, MD, Domenico Borzomati, MD, Bruno Vincenzi, MD, Roberto Coppola, MD, Giuseppe Tonini, MD, Giuseppe Avvisati, MD, PhD

Blood (2004) 104 (11): 4044.

https://doi.org/10.1182/blood.V104.11.4044.4044

Published: 2004

Journal Articles

Identification and Characterization of Endothelial Glycoprotein Ib Using Viper Venom Proteins Modulating Cell Adhesion

Li Tan, M. Anna Kowalska, Gabriel M. Romo, Jose A. Lopez, Zbigniew Darzynkiewicz, Stefan Niewiarowski

Blood (1999) 93 (8): 2605–2616.

https://doi.org/10.1182/blood.V93.8.2605

Published: 1999

NARROW

Case Report: A 19-Years Old Patient with Haemophilia a with High Response Inhibitor Screening and Quantitation and the Bethesda Method

Circulating Levels of Rivaroxaban Provide Different Results in Different Clot Based and Amidolytic Assays. a Study on Patients Treated with Two Different Dosages of Rivaroxaban

Detection of Lupus Anticoagulant In Women with Obstetric complications

Increased Anti-Protein Z and Protein S Antibodies in Patients with Anti-Phospholipid Antibodies and/or Lupus Inhibitor.

Changes in Components of the Natural Coagulation Inhibitor System, in Patients with Antiphospholipid Antibodies and/or the Lupus Inhibitor.

High Prevalence of Anti-Protein Z and Anti-Protein S Antibodies in Patients with Other Serological Markers for Antiphospholipid Antibodies.

Clinical Impact of Increasing the Sensitivity of Activated Partial Thromboplastin Time (aPTT) Reagent for Lupus Anticoagulant.

Physiologic Inhibitors of Coagulation, Thrombophilic Acquired Factors and Venous Thromboembolism in Gastrointestinal Cancer Patients.

Identification and Characterization of Endothelial Glycoprotein Ib Using Viper Venom Proteins Modulating Cell Adhesion

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only